Oligonucleotide Therapy Market Expansion to $9.66 Billion by 2029: Key Drivers and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the oligonucleotide therapy market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Oligonucleotide Therapy Market Today And What Will It Reach By 2029?

The oligonucleotide therapy market has experienced swift expansion recently. Its valuation is projected to rise from $5.61 billion in 2024 to $6.2 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.5%. Historically, this expansion has been driven by increased investment in research and development, the introduction of initial therapies into the market, the emergence of gene editing techniques, significant early therapeutic breakthroughs, and the advent of RNAi and antisense oligonucleotide technologies.

The oligonucleotide therapy market is anticipated to experience substantial growth in the upcoming years, with its size predicted to reach $9.66 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is largely driven by increased research and development investments, wider global market penetration, the broadening of therapeutic areas, innovative disease modification strategies, and responsive regulatory adaptations. Prominent trends expected in this period include the development of customized therapies, enhancements in delivery systems, advancements in RNA interference (RNAI), continued innovation in antisense oligonucleotides, and the integration of gene editing techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

What Factors Are Boosting The Oligonucleotide Therapy Market?

The increasing global prevalence of cancer is anticipated to drive the expansion of the oligonucleotide therapy market throughout the forecast period. For example, the American Cancer Society reported in January 2022 that the United States was projected to see 1.9 million new cancer diagnoses and 609,360 deaths attributable to cancer, equating to approximately 1,670 daily fatalities. Globally, lung, prostate, bowel, and female breast cancer represent the four most prevalent forms, collectively responsible for 43% of all new cancer cases. Consequently, the escalating worldwide cancer incidence rates are expected to stimulate demand within the oligonucleotide therapy market in the coming years.

How Is The Oligonucleotide Therapy Market Categorized By Application, Type, And Region?

The oligonucleotide therapy market covered in this report is segmented –

1) By Type: Antisense Oligonucleotide, Aptamer, Other Types

2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User

3) By End User: Hospitals, Research Institutes

Subsegments:

1) By Antisense Oligonucleotide: RNA-Targeted Antisense Oligonucleotides, DNA-Targeted Antisense Oligonucleotides, Chemically Modified Antisense Oligonucleotides

2) By Aptamer: DNA Aptamers, RNA Aptamers, Small Molecule Aptamers

3) By Other Types: siRNA (Small Interfering RNA), miRNA (Micro RNA), DNAzyme And Ribozymes, Synthetic Oligonucleotides For Gene Editing

How Are Technological Trends Affecting The Oligonucleotide Therapy Market Growth?

Companies within the oligonucleotide therapy market, including developers and providers, are dedicating investments to research and development endeavors aimed at remodeling therapy designs to diminish patient side effects. The advanced and novel oligonucleotides facilitate precision medicine strategies and can be formulated to selectively target any gene while producing minimal adverse effects. Furthermore, they aid in targeting patient-specific sequences responsible for rare diseases. In April 2023, the FDA sanctioned Qalsody, an antisense oligonucleotide (ASO), for use in patients suffering from amyotrophic lateral sclerosis (ALS) linked to a mutation in the superoxide dismutase 1 (SOD1) gene. Qalsody functions by targeting SOD1 mRNA to reduce the production of SOD1 protein.

Who Are The Global Leaders Steering The Oligonucleotide Therapy Market Forward?

Major companies operating in the oligonucleotide therapy market include Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Gilead Sciences Inc., BioNTech SE, Moderna Inc., Biogen Inc., Jazz Pharmaceuticals plc, QIAGEN Company, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., SomaGenics Inc., Wave Life Sciences Ltd., Exicure Inc., Avidity Biosciences Inc., Miragen Therapeutics Inc., ProQR Therapeutics NV, Regulus Therapeutics Inc., Kastle Therapeutics LLC, Santaris Pharma A/S, InteRNA Technologies B.V., Dynacure S.A., Arcturus Therapeutics Holdings Inc., Intellia Therapeutics Inc., Regeneron Pharmaceuticals Inc., Editas Medicine Inc., Evox Therapeutics Ltd., PepGen Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Oligonucleotide Therapy Market?

North America was the largest region in the oligonucleotide therapy market in 2024. The regions covered in the oligonucleotide therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3398&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Therapy Market 2025, By The Business Research Company

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Antiemetics And Antinauseants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Pharmaceutical Api Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-api-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795